Manager, Business Intelligence - Oncology
CurrentOncology business/competitive intelligence lead supporting cross-functional teams (Medical, Marketing, RWE, Global) focused on J&J's leukemia/lymphoma and Lung cancer portfolioProducts: IMBRUVICA (ibrutinib), RYBREVANT (amivantamab), and LAZCLUZE (lazertinib)